Neurotoxin pricing is the single largest variable in your injectable margin equation. A 10% swing in per-unit cost directly hits bottom line—and those swings happen constantly through rebate programs, volume tiers, and manufacturer incentives. This tracker breaks down the real economics: what you actually pay per unit, how rebate programs work, and where the margin leakage happens. Unlike filler, where crosslink chemistry and rheology drive clinical choice, toxin selection is often driven by economics and rebate structure. Understanding the spread between wholesale and your injection price, and how loyalty programs stack, is the difference between a 65% margin and a 50% margin on your highest-volume procedure.